8-K current report · filed May 1, 2026

ACADIA PHARMACEUTICALS INC (ACAD) 8-K Current Report: May 1, 2026

Item 5.02Item 7.01Item EX-99.1ACAD overview

Short answer

ACADIA PHARMACEUTICALS INC (ACAD) filed an 8-K current report with the SEC on May 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). R&D head Elizabeth H.Z. Thompson announced planned retirement for personal reasons.

ACADIA PHARMACEUTICALS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • R&D head Elizabeth H.Z. Thompson announced planned retirement for personal reasons
  • Thompson remains through successor appointment, limiting near-term leadership disruption
  • Consulting role through end-2026 supports planned Phase 2 remlifanserin readout
  • Replacement search underway, creating execution risk around R&D leadership transition

Item 7.01 · Regulation FD Disclosure

  • Disclosure flags Dr. Thompson’s anticipated retirement, creating leadership-transition risk for research and development
  • Continued service during a transition and later consulting role may preserve institutional knowledge
  • Search underway for a replacement Head of Research and Development, making successor quality material to pipeline execution
  • Timing and final structure remain uncertain, with outcomes potentially differing from current expectations

Item EX-99.1 · Exhibit EX-99.1

  • Head of R&D Elizabeth H.Z. Thompson plans year-end retirement for personal reasons
  • Thompson remains until successor appointment, then consults through at least end-2026
  • Leadership transition overlaps Phase 2 remlifanserin readouts in ADP and LBDP and early Phase 3 execution
  • Successor search underway, creating execution risk for Acadia’s neurological and rare-disease pipeline
  • Ongoing trials remain blinded and recruiting; outcomes are not yet known

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ACADIA PHARMACEUTICALS INC 8-K filings

Get the next ACAD 8-K as it lands

Follow ACAD for push alerts, or ask the research agent what this filing means.